Maruf Shomik, Nath Proggananda, Aktar Fatima, Basher Ariful
NCSD International Centre for diarrhoeal Diseases & Research (icddr.b) Dhaka Bangladesh.
Infectious Diseases and Tropical Medicine Department Mymensingh Medical College and Hospital Mymensingh Bangladesh.
Pharmacol Res Perspect. 2016 Oct 21;4(6):e00269. doi: 10.1002/prp2.269. eCollection 2016 Dec.
Although liposomal amphotericin B (AmBisome) is considered as the first-line treatment for New Kala-azar, there is not enough evidence on the dosage formulation in children and its effect on them. Being considered as the safest drug for treatment of Kala-azar, this case of AmBisome-induced avascular necrosis now gives rise to the question; whether it is actually safe enough and if a dosage modification is needed in case of children. This so far, to the best of our knowledge, is the first instance of such severe adverse event due to AmBisome administration.
尽管脂质体两性霉素B(安必素)被视为治疗新型黑热病的一线药物,但关于儿童用药剂量配方及其对儿童的影响,目前尚无足够证据。安必素被认为是治疗黑热病最安全的药物,然而此次安必素诱发无血管性坏死的病例引发了一个问题:它是否真的足够安全,以及儿童用药时是否需要调整剂量。据我们所知,这是迄今为止因使用安必素而导致如此严重不良事件的首例。